Ignite Creation Date:
2025-12-24 @ 11:02 PM
Ignite Modification Date:
2025-12-25 @ 8:33 PM
Study NCT ID:
NCT03850769
Status:
UNKNOWN
Last Update Posted:
2020-03-10
First Post:
2019-02-20
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Neoadjuvant Nab-Paclitaxel and S-1 in Borderline Resectable Pancreatic Cancer
Sponsor:
Peking Union Medical College Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-05-01
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-04
Completion Date Type:
ESTIMATED
First Submit Date:
2019-02-20
First Submit QC Date:
None
Study First Post Date:
2019-02-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-03-08
Last Update Post Date:
2020-03-10
Last Update Post Date Type:
ACTUAL